2.42
price down icon11.68%   -0.32
 
loading

23 Andme Holding Co Aktie (ME) Neueste Nachrichten

pulisher
Feb 21, 2025

23andMe CEO Anne Wojcicki and New Mountain Capital offer to take company private - Marketscreener.com

Feb 21, 2025
pulisher
Feb 17, 2025

Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach - ACCESS Newswire

Feb 17, 2025
pulisher
Feb 07, 2025

23andMe's Anne Wojcicki open (again) to third-party buyout of genetic testing companySan Francisco Business Times - The Business Journals

Feb 07, 2025
pulisher
Feb 06, 2025

23andMe Holding Co. SEC 10-Q Report - TradingView

Feb 06, 2025
pulisher
Feb 01, 2025

23andMe Launches New Genetic Report on Osteoporosis - GlobeNewswire

Feb 01, 2025
pulisher
Jan 31, 2025

23andMe On The Brink? Exploring a Potential Sale Amid Financial Struggles! - Smartkarma

Jan 31, 2025
pulisher
Jan 31, 2025

23andMe Sags on New Report - Baystreet.ca

Jan 31, 2025
pulisher
Jan 31, 2025

23andMe Holding Co. (ME) Launches New Genetic Report on Osteoporosis - StreetInsider.com

Jan 31, 2025
pulisher
Jan 29, 2025

23andMe Faces Financial Challenges Amid Revenue Growth - TipRanks

Jan 29, 2025
pulisher
Jan 29, 2025

23Andme Holding Co earnings missed by $0.86, revenue topped estimates - Investing.com India

Jan 29, 2025
pulisher
Jan 29, 2025

23andMe Board Explores Strategic Alternatives Amid Restructuring - GuruFocus.com

Jan 29, 2025
pulisher
Jan 29, 2025

23andMe Reports Third Quarter Fiscal Year 2025 Financial Results - GlobeNewswire

Jan 29, 2025
pulisher
Jan 29, 2025

23andMe Holding Begins Exploring Strategic Alternatives -January 29, 2025 at 03:49 am EST - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

23andMe Holding Co. (ME) Reports Q3 Loss of $1.02 - StreetInsider.com

Jan 29, 2025
pulisher
Jan 28, 2025

ME23andMe Holding Co. Latest Stock News & Market Updates - StockTitan

Jan 28, 2025
pulisher
Jan 28, 2025

23andMe (NASDAQ:ME) Releases Quarterly Earnings Results - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

23andMe says it's exploring alternatives, including a sale (ME:NASDAQ) - Seeking Alpha

Jan 28, 2025
pulisher
Jan 28, 2025

23andMe Special Committee Announces Exploration of Strategic Alternatives - The Manila Times

Jan 28, 2025
pulisher
Jan 28, 2025

23andMe Holding Co. (ME) to explore strategic alternatives, including possible sale - StreetInsider.com

Jan 28, 2025
pulisher
Jan 28, 2025

23andMe Puts Itself Up for Sale: Major DNA Testing Company Could Change Hands - StockTitan

Jan 28, 2025
pulisher
Jan 28, 2025

23andMe Holding Co. (ME) Halted, News Pending - StreetInsider.com

Jan 28, 2025
pulisher
Jan 27, 2025

ME INVESTIGATION ALERT: 23andMe Holding Co. Shareholders are Alerted to Contact BFA Law regarding Ongoing Investigation into the Company (Nasdaq:ME) - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 27, 2025

ME INVESTOR UPDATE: BFA Law Alerts 23andMe Holding Co. Shareholders to Contact the Firm about its Investigation into the Company’s Board of Directors (Nasdaq:ME) - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 25, 2025

Deal Dispatch: Lovely Day To Sell Guinness? Plus, 23andMe To Rid Lineage Of Lemonaid - Benzinga

Jan 25, 2025
pulisher
Jan 23, 2025

Predictive Genetic Testing and Consumer Genomics Market Research 2024-2034: Expanding DTC Genetic Testing, Consumer Interest in Personalized Healthcare, Awareness of Early Detection and Prevention - GlobeNewswire Inc.

Jan 23, 2025
pulisher
Jan 17, 2025

23andMe Has Been Reportedly Quietly Explores a Possible Sale of its Telehealth Business, Lemonaid - Marketscreener.com

Jan 17, 2025
pulisher
Jan 17, 2025

23andMe launches Discover23 to help accelerate genetics research - European Pharmaceutical Manufacturer

Jan 17, 2025
pulisher
Jan 16, 2025

NewView Capital Partners I LLC Has $3.16 Million Holdings in 23andMe Holding Co. (NASDAQ:ME) - MarketBeat

Jan 16, 2025
pulisher
Jan 12, 2025

Jane Street Group LLC Sells 1,561,678 Shares of 23andMe Holding Co. (NASDAQ:ME) - MarketBeat

Jan 12, 2025
pulisher
Jan 08, 2025

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit's Trusted Technology - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

23andMe Launches Discover23 to Help Accelerate Large-Scale - GlobeNewswire

Jan 08, 2025
pulisher
Jan 08, 2025

23andMe Launches Discover23 Platform with Massive 4.7B Genetic Data Points for Medical Research - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

23andMe (NASDAQ:ME) Stock Price Down 0.3%Should You Sell? - MarketBeat

Jan 07, 2025
pulisher
Jan 03, 2025

3 Promising US Penny Stocks With Over $9M Market Cap - Yahoo Finance

Jan 03, 2025
pulisher
Jan 02, 2025

23andMe Stock Price Prediction: 2024, 2025, 2030 - Benzinga

Jan 02, 2025
pulisher
Dec 14, 2024

23andMe Holding Co. (NASDAQ:ME) Short Interest Down 16.6% in November - MarketBeat

Dec 14, 2024
pulisher
Dec 04, 2024

23Andme Holding Co earnings missed by $2.16, revenue topped estimates - Investing.com Nigeria

Dec 04, 2024
pulisher
Dec 03, 2024

US Penny Stocks: 3 Picks With Market Caps Under $200M - Simply Wall St

Dec 03, 2024
pulisher
Dec 02, 2024

Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - MSN

Dec 02, 2024
pulisher
Nov 30, 2024

23andMe (NASDAQ:ME) Trading 13.1% HigherHere's Why - MarketBeat

Nov 30, 2024
pulisher
Nov 27, 2024

23andMe CEO Anne Wojcicki responds to critics, shares plan for company's future: "Essential for us to restructure" - CBS News

Nov 27, 2024
pulisher
Nov 27, 2024

23andMe’s stock falls after company says there’s substantial doubt it can stay in business - MSN

Nov 27, 2024
pulisher
Nov 22, 2024

23andMe shares dip as Q2 loss widens despite revenue beat By Investing.com - Investing.com Nigeria

Nov 22, 2024
pulisher
Nov 21, 2024

Do Redditors Think That 23andMe Holding Co. (ME) Has a Big Upside Potential? - Insider Monkey

Nov 21, 2024
pulisher
Nov 20, 2024

Struggling 23andMe Is Exploring Splitting the DNA Company in Two - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

23andMe inks research deal with Mirador Therapeutics By Investing.com - Investing.com Canada

Nov 20, 2024
diagnostics_research DGX
$172.24
price up icon 0.06%
$162.31
price down icon 3.50%
diagnostics_research LH
$249.85
price up icon 0.27%
diagnostics_research WAT
$374.82
price down icon 1.57%
diagnostics_research MTD
$1,286.54
price down icon 1.27%
diagnostics_research IQV
$191.04
price down icon 1.53%
Kapitalisierung:     |  Volumen (24h):